EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. (Nat Commun, Nov 2020)
Yi Bao 1 2, Gokce Oguz 2, Wee Chyan Lee 2, Puay Leng Lee 2, Kakaly Ghosh 2, Jiayao Li 3, Panpan Wang 3, Peter E Lobie 1 4, Sidse Ehmsen 5, Henrik J Ditzel 5 6, Andrea Wong 7, Ern Yu Tan 8, Soo Chin Lee 9 10, Qiang Yu 11 12 13 Author Information 1Cancer Science Institute of Singapore, Yong Loo …